APA (7th ed.) Citation

Cai, B., Li, X., Huang, X., Ma, T., Qu, B., Yu, W., . . . Liu, F. (2021). Case Report: Sequential Combination Targeted Therapy With Type I and II MET Inhibitors in a Metastatic EGFR-Mutated, MET-Amplified NSCLC Patient With Acquired MET Y1230H Mutation. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Cai, Boning, et al. Case Report: Sequential Combination Targeted Therapy With Type I and II MET Inhibitors in a Metastatic EGFR-Mutated, MET-Amplified NSCLC Patient With Acquired MET Y1230H Mutation. Frontiers Media S.A, 2021.

MLA (8th ed.) Citation

Cai, Boning, et al. Case Report: Sequential Combination Targeted Therapy With Type I and II MET Inhibitors in a Metastatic EGFR-Mutated, MET-Amplified NSCLC Patient With Acquired MET Y1230H Mutation. Frontiers Media S.A, 2021.